Expanded Carrier Screening Market, Global Outlook and Forecast 2023-2030
Expanded reproductive carrier screening is a more comprehensive carrier screen designed for couples, prior to pregnancy. This screen tests the biological mother and the biological father to determine their chance of having a child affected with one or more inherited genetic conditions. Testing covers over 250 different conditions.
This report aims to provide a comprehensive presentation of the global market for Expanded Carrier Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Expanded Carrier Screening. This report contains market size and forecasts of Expanded Carrier Screening in global, including the following market information:
- Global Expanded Carrier Screening Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The global Expanded Carrier Screening market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Customized Panel Testing Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Expanded Carrier Screening include Invitae, Fulgent Genetics, LabCorp, VCGS, Myriad Genetics, Eurofins Scientific and BGI Genomics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Expanded Carrier Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Expanded Carrier Screening Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Expanded Carrier Screening Market Segment Percentages, by Type, 2022 (%)
- Customized Panel Testing
- Predesigned Panel Testing
Global Expanded Carrier Screening Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Expanded Carrier Screening Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Reference Laboratories
- Physician Offices & Clinics
- Other End Users
Global Expanded Carrier Screening Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Expanded Carrier Screening Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Expanded Carrier Screening revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Expanded Carrier Screening revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Invitae
- Fulgent Genetics
- LabCorp
- VCGS
- Myriad Genetics
- Eurofins Scientific
- BGI Genomics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Expanded Carrier Screening, market overview.
Chapter 2: Global Expanded Carrier Screening market size in revenue.
Chapter 3: Detailed analysis of Expanded Carrier Screening company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Expanded Carrier Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
